StockWatch
·

Rhi Magnesita India Ltd

BSE: 534076

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
870.25
+10.3%+8.0%
Expenditure
765.39
+3.6%+2.9%
Net Profit
78.19
+112.5%+68.0%
OPM %
13.94%
+88.97pp+3.75pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-807.88-333.94140.01613.961.1KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

RHI Magnesita Q1 FY27: consol PAT +83% YoY to ₹64.6 Cr, margin expands to 13.6%

refractories · margin expansion · consolidated pat growth

ResultsQ1 FY2711 Aug 20263 minIndustrials & Infra

Pankaj Malhan's First Quarter—Volumes and the MINPRO Ramp

refractories · volumes · circularity

Result previewQ1 FY2708 Aug 20263 minIndustrials & Infra
Latest
Board Meeting11 Aug, 4:24 pm

RHI Magnesita Q1 FY27: consol PAT +83% YoY to ₹64.6 Cr, margin expands to 13.6%

RHI Magnesita India's consolidated revenue rose 5.6% YoY to ₹1,013.97 Cr (+8.8% QoQ) in Q1 FY27 (quarter ended June 30, 2026), while consolidated net profit jumped 83.2% YoY to ₹64.61 Cr from ₹35.27 Cr a year ago — both figures clean of one-off items on either side of the comparison, so the growth is organic. Standalone PAT grew a slower 68.0% YoY to ₹78.19 Cr on 7.2% revenue growth to ₹863.45 Cr; the wider consolidated gain implies the group's subsidiaries, including RHI Magnesita India Refractories Ltd (RHIMIRL, whose carrying value was written down at the standalone level last quarter), contributed disproportionately to the improvement — Intermetal Engineers and Ashwath Technologies alone added ₹6.78 Cr revenue and ₹1.03 Cr PAT to the consolidated numbers this quarter. The operating margin (EBITDA excluding other income) expanded to roughly 13.6% of revenue from 10.65% a year ago, and net margin rose to 6.37% from 3.67%. Sequentially the quarter is a clean bounce-back from Q4 FY26's reported net loss, but that loss was entirely a function of the ~Rs.556 Cr consolidated goodwill impairment taken against RHIMIRL and is not a like-for-like base; on an adjusted basis Nuvama had pegged Q4 FY26 adjusted EBITDA margin at 12.1% (against its own estimate of a higher print), so this quarter's ~13.6% still marks genuine sequential margin improvement, consistent with price hikes flowing through. On the street side, no discrete Q1 FY27 PAT estimate was found, but Nuvama's post-Q4 note explicitly expected margin recovery in Q1 FY27 on price hikes and a robust order book, modelling 13%/13.5% EBITDA margins for FY27E/28E — the actual ~13.6% op margin already clears that full-year bar in the first quarter, a beat on trajectory even without a hard PAT comparison. Management gives no formal quarter-specific guidance on record for Q1 FY27 itself; the only prior guidance in our records (from the Q3 FY26 call) targeted Q4 FY26 margins near 13.7%, a bar that quarter missed on an adjusted basis (~12.1%), so this print is a partial recovery toward, not a return to, that earlier level. No press release commentary was available for this filing, so framing rests on the reported figures alone. The quarter also carries governance overhang: statutory auditor Price Waterhouse Chartered Accountants LLP signed this quarter's limited review on August 11, 2026 but has separately tendered resignation from both the company and RHIMIRL effective August 14, 2026, and Pankaj Malhan took over as the parent's MD & CEO from July 1, 2026 (just after quarter-end) under a broader leadership rejig, with Parmod Sagar continuing as Chairman. Neither event has a financial bearing on this quarter's numbers. Subsequent to quarter-end, the company also incorporated a 51:49 JV with Khemka Refractories (RHI Khemka Minpro) for mineral processing on July 16, 2026, which the company states has no financial impact on the Q1 FY27 results.

11 Aug 2026, 04:24 pm

Corporate Events

Board MeetingRHIM
2026
11Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing
Board MeetingRHIM
2026
3Aug

Board Meeting

The Board of Directors of RHIM Khemka MINPRO Private Limited…

BSE Filing
Board MeetingRHIM
2026
30Jun

Board Meeting

The Board of Directors considered and approved the resignati…

BSE Filing
Board MeetingRHIM
2026
25Jun

Board Meeting

The Board of Directors approved entering into a Joint Ventur…

BSE Filing
Board MeetingRHIM
2026
28May

Board Meeting

The board meeting is scheduled to consider and approve the a…

BSE Filing
DividendRHIM
2025
12Sep

₹2.5 / share

BSE Filing
Board MeetingRHIM
2024
7Nov

Board Meeting

Consider, approve and take on record unaudited financial res…

BSE Filing
DividendRHIM
2024
6Sep

₹2.5 / share

BSE Filing
DividendRHIM
2024
29May

₹2.5 / share

BSE Filing
Board MeetingRHIM
2024
29May

Board Meeting

Consider and approve and take on record audited financial re…

BSE Filing
Board MeetingRHIM
2024
13Feb

Board Meeting

Consider, approve and take on record the unaudited standalon…

BSE Filing
Board MeetingRHIM
2023
8Nov

Board Meeting

Consider, approve and take on record the unaudited standalon…

BSE Filing